Celltrion Ltd.

Celltrion Ltd. - Incheon, South Korea; formed in 2002 by VaxGen and three Korean partners: Nexol Corp., KT Corp., and J. Stephen Co. Ventures Ltd.; VaxGen provides technology, know-how and training while Korean partners provide funding; VaxGen is the single largest stockholder (32%); Celltrion has four 12,500-liter bioreactors online and adding 50,000 liters of capacity by 2010.

Related product monographs:

1. Anthrax Vaccine, rDNA -- Manuf. ; R&D ; Tech. ; Former
2. CTLA4-Ig, rDNA -- Manuf.
3. TNF Mab, rDNA/Celltrion -- Manuf. ; R&D ; Tech.
4. TNF Receptor-IgG Fc, rDNA -- Patent dispute

Location - Incheon Korea For

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute